US · USD
CRL
Charles River Laboratories
- Day's range
- $292.02 – $312.26
- Day's volume
- $402.5M
- 52-week range
- $149.93 – $310.77
Follow CRL in the Fuolio
See how CRL weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountCRL in numbers
- Market cap
- $14.8B
- P/E
- -62.22
- P/B
- 5.22
- Dividend yield (12m)
- 0.00%
- Net debt/EBITDA
- -0.48
CRL price history
CRL risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +74.45% | +57.69% | -15.06% |
| Volatility (annualized) | 39.70% | 41.97% | 39.30% |
| Largest drawdown | -20.67% | -56.22% | -68.52% |
| Positive months | 8/12 | 18/36 | 26/60 |
How much did investing in CRL return?
$1,000.00 invested on 11/01/2021 would be worth $849.40 today.
- Value today in CRL
- $849.40
- Return over the period
- -15.06%
- Return per year
- -3.26%
- In the S&P 500
- $1,702.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
CRL fundamentals
Valuation
- P/E-62.22
- P/B5.22
- EV/EBITDA37.75
- EV/EBIT162.51
- EV/Revenue3.66
- P/EBIT164.58
- P/S3.71
- P/OCF25.48
- P/FCF—
- Earnings yield0.62%
- PEG ratio—
- Earnings per share-$5.00
- Book value per share$59.48
Debt
- Net debt-$186.6M
- Net debt/EBITDA-0.48
- Net debt/Equity-0.07
- Debt/Equity0.00
- Current ratio1.35
- Quick ratio1.04
- Cash ratio0.17
Efficiency
- Gross margin—
- EBITDA margin9.70%
- Operating margin2.25%
- Net margin-5.96%
- Asset turnover0.53
Profitability
- ROE-8.40%
- ROA-3.17%
- ROIC2.24%
- Payout—
Growth
- Revenue CAGR (5 years)4.09%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
CRL's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -68.03 | 425.20 | 25.58 | 22.85 | 48.65 | 34.14 | 29.68 | 24.11 |
| P/B | 3.10 | 2.73 | 3.37 | 3.73 | 7.50 | 5.88 | 4.58 | 4.14 |
| EV/EBITDA | 22.42 | 15.70 | 12.74 | 11.39 | 21.95 | 18.36 | 13.25 | 14.03 |
| Earnings per share | -$2.93 | $0.43 | $9.24 | $9.54 | $7.74 | $7.32 | $5.15 | $4.69 |
| Book value per share | $64.29 | $67.68 | $70.05 | $58.38 | $50.21 | $42.48 | $33.39 | $27.32 |
| ROE | -4.56% | 0.64% | 13.20% | 16.34% | 15.42% | 17.23% | 15.42% | 17.18% |
| ROIC | 0.85% | 1.89% | 15.35% | 18.76% | 21.35% | 18.30% | 20.50% | 9.63% |
| EBITDA margin | 10.67% | 14.55% | 22.55% | 24.01% | 24.16% | 22.83% | 20.95% | 21.76% |
| Net margin | -3.59% | 0.55% | 11.49% | 12.23% | 11.04% | 12.46% | 9.61% | 9.99% |
| Net debt/EBITDA | -0.50 | -0.33 | -0.29 | -0.24 | -0.28 | -0.27 | -0.37 | 2.96 |
CRL's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $4B | $4B | $4.1B | $4B | $3.5B | $2.9B |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | $428.5M | $589.1M | $931.4M | $954.8M | $855.4M | $667.7M |
| EBIT | $25.2M | $227.3M | $617.3M | $651M | $589.9M | $432.7M |
| Financial result | — | — | — | — | — | — |
| Income before tax | -$99.5M | $93.1M | $581.3M | $623M | $480.7M | $447.1M |
| Income tax | -$42.7M | -$67.8M | -$100.9M | -$130.4M | -$81.9M | -$81.8M |
| Net income | -$144.3M | $22.2M | $474.6M | $486.2M | $391M | $364.3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does CRL pay dividends?
CRL has no distributions on record.
About Charles River Laboratories
- Sector
- Services
Questions about CRL
How much is CRL today?
CRL is at $310.77 (7.09% on the day), last traded on 10/05/2026.
What are the P/E and P/B of CRL?
CRL trades at a P/E of -62.22 and a P/B of 5.22.
How much did CRL return in 12 months?
CRL returned 74.45% in 12 months, with annualized volatility of 39.70% and a largest drawdown of -20.67%.